The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression

Lin Xiao, Mawar Karsa, Emma Ronca, Angelika Bongers, Angelika Kosciolek, Ali El-Ayoubi, Jezrael L. Revalde, Janith A. Seneviratne, Belamy B. Cheung, Laurence C. Cheung, Rishi S. Kotecha, Andrea Newbold, Stefan Bjelosevic, Greg M. Arndt, Richard B. Lock, Ricky W. Johnstone, Andrei V. Gudkov, Katerina V. Gurova, Michelle Haber, Murray D. Norris, Michelle J. Henderson, Klaartje Somers

Open source

DOI: 10.3389/fonc.2022.863329
Published: 2022-05-23
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2022.863329,
  title = {The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression},
  author = {Lin Xiao and Mawar Karsa and Emma Ronca and Angelika Bongers and Angelika Kosciolek and Ali El-Ayoubi and Jezrael L. Revalde and Janith A. Seneviratne and Belamy B. Cheung and Laurence C. Cheung and Rishi S. Kotecha and Andrea Newbold and Stefan Bjelosevic and Greg M. Arndt and Richard B. Lock and Ricky W. Johnstone and Andrei V. Gudkov and Katerina V. Gurova and Michelle Haber and Murray D. Norris and Michelle J. Henderson and Klaartje Somers},
  year = {2022},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2022.863329},
  url = {https://doi.org/10.3389/fonc.2022.863329}
}

RIS

TY  - JOUR
TI  - The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression
AU  - Lin Xiao
AU  - Mawar Karsa
AU  - Emma Ronca
AU  - Angelika Bongers
AU  - Angelika Kosciolek
AU  - Ali El-Ayoubi
AU  - Jezrael L. Revalde
AU  - Janith A. Seneviratne
AU  - Belamy B. Cheung
AU  - Laurence C. Cheung
AU  - Rishi S. Kotecha
AU  - Andrea Newbold
AU  - Stefan Bjelosevic
AU  - Greg M. Arndt
AU  - Richard B. Lock
AU  - Ricky W. Johnstone
AU  - Andrei V. Gudkov
AU  - Katerina V. Gurova
AU  - Michelle Haber
AU  - Murray D. Norris
AU  - Michelle J. Henderson
AU  - Klaartje Somers
PY  - 2022
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2022.863329
UR  - https://doi.org/10.3389/fonc.2022.863329
ER  -

APA

Xiao, L., Karsa, M., Ronca, E., Bongers, A., Kosciolek, A., El-Ayoubi, A., Revalde, J. L., Seneviratne, J. A., Cheung, B. B., Cheung, L. C., Kotecha, R. S., Newbold, A., Bjelosevic, S., Arndt, G. M., Lock, R. B., Johnstone, R. W., Gudkov, A. V., Gurova, K. V., Haber, M., Norris, M. D., Henderson, M. J., & Somers, K. (2022). The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression. Frontiers in Oncology. https://doi.org/10.3389/fonc.2022.863329

Source records

crossref · retrieved 2026-11-05T04:57:15.530Z